GBT (Global Blood Therapeutics, Inc.)
@GBT_news
We are a biopharma that is passionate & committed to improving the lives of people with SCD. Community guidelines: https://t.co/VJfScPdvYU
ID:821429809607622656
http://gbt.com 17-01-2017 18:51:42
2,4K Tweets
2,1K Followers
291 Following
Follow People
Pfizer Inc. We are so grateful for our employees and their work over these past 11 years to help people living with #SickleCell disease. Joining Pfizer Inc. is an exciting milestone that enables us to accelerate our mission on behalf of patients. Our commitment is stronger than ever.
We’re proud to announce GBT CEO Dr. Ted Love has been nominated for the California Life Sciences (CLS) #Pantheon2022 Leadership award. Congrats to everyone who was nominated. Cast your vote by October 14: califesciences.org/pantheon-votin…
This month, Tevin Coleman and Akilah Murib Coleman will be at the SCDAA convention to talk about their family’s #SickleCell disease playbook. Register today to join the conversation: bit.ly/3Slkgv1.
Watch GBT CEO Dr. Ted Love as part of the NatlBlkChrchInitive lecture series discussing the history and importance of participation in #SickleCell clinical trials⬇️.
A big thank you to the GBTers who supported the many people impacted by #SickleCell by participating in the Sickle Cell Anemia Awareness San Francisco 9th Annual KMJ Sickle Cell Warrior Walk last weekend. #SickleCell AwarenessMonth
GBT CEO Dr. Ted Love spoke with steve usdin about how racial prejudice has slowed the development of treatments for #SickleCell disease and how our success will stimulate investment in new therapies. Watch the full interview ⬇️.
Join us in encouraging your elected officials to co-sponsor the #SickleCell Disease Treatment Centers Act of 2022! Visit bit.ly/3xDj3Xq, to easily identify your elected officials, and it will help auto-populate a letter and send it directly to your Member of Congress.
We’re pleased to announce that our medicine for the treatment of #SickleCell disease has received its third Gulf Cooperation Council approval in Kuwait, after UAE and Oman. We are immensely proud to be delivering a treatment option for patients across the world.
GBT CEO Dr. Ted Love joins steve usdin on The BioCentury Show tomorrow, September 22. Check it out here: biocentury.com/the-biocentury…
This #SickleCellAwarenessMonth we celebrate advocates like NFL running back Tevin Coleman and his family, who continue to help spread awareness about this complex inherited condition.
Today, Rep. Barbara Lee, Rep. Danny K. Davis, Senator Chris Van Hollen and Sen. Cory Booker introduced the #SickleCell Disease Treatment Centers Act of 2022 in Congress. We commend their dedication and fully support this step to advance #HealthEquity for the #SCD community. ir.gbt.com/news-releases/…
To kickoff #HispanicHeritageMonth , we’re sharing Anais’ powerful journey and the importance of a support system when living with #SickleCell . See her full story: sicklecellspeaks.com/our-stories/an…
Featured Post from #NABJNAHJ22 Partner GBT (Global Blood Therapeutics, Inc.): Why Sickle Cell Disease is a Prime Example of Health Inequity in the Black Community and What Can Be Done to Empower a Brighter Future. Read Now: bit.ly/3em2mt3